Texas Health Resources   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Arlington TX United States (1997)

Organization Overview

First Clinical Trial
1999
NCT00708487
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Texas Health Resource | Texas Health Resources

Active Ingredients

Drugs in Phase 3 Trials (3)

amlodipine (norvasc) (3 trials)

atorvastatin (lipitor) (1 trial)

losartan (cozaar) (3 trials)

Drugs in Phase 1 Trials (1)

phenylephrine (Prefrin) (1 trial)

Drugs in Other Trials (3)

gabapentin (neurontin) (1 trial)

nitric acid (1 trial)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Anorexia (Phase 1)

Anorexia Nervosa (Phase 1)

Cognitive Dysfunction (Phase 3)

Heart Failure (Phase 1)

Hypertension (Phase 2)

Intracranial Hypertension (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 7